Insider Transactions in Q4 2021 at Resmed Inc (RSMDF)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 15
2021
|
Michael J. Farrell Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,675
-1.38%
|
$1,447,125
$255.53 P/Share
|
|
Dec 15
2021
|
Michael J. Farrell Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,675
+1.36%
|
$323,475
$57.76 P/Share
|
|
Dec 15
2021
|
Robert Andrew Douglas Special Advisor |
SELL
Open market or private sale
|
Direct |
8,000
-31.78%
|
$2,048,000
$256.52 P/Share
|
|
Dec 15
2021
|
Robert Andrew Douglas Special Advisor |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+24.11%
|
$464,000
$58.24 P/Share
|
|
Dec 10
2021
|
Brett Sandercock Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,500
-2.3%
|
$660,000
$264.92 P/Share
|
|
Dec 10
2021
|
Brett Sandercock Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+2.25%
|
$142,500
$57.76 P/Share
|
|
Dec 03
2021
|
David Pendarvis Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
1,544
-1.3%
|
$396,808
$257.93 P/Share
|
|
Dec 01
2021
|
James Hollingshead President, Sleep Business |
SELL
Open market or private sale
|
Direct |
2,400
-3.03%
|
$614,400
$256.84 P/Share
|
|
Nov 30
2021
|
Michael J. Farrell Chief Executive Officer |
BUY
Bona fide gift
|
Indirect |
3,880
+50.0%
|
-
|
|
Nov 30
2021
|
Michael J. Farrell Chief Executive Officer |
SELL
Bona fide gift
|
Indirect |
3,880
-43.26%
|
-
|
|
Nov 24
2021
|
Justin Leong Chief Product Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,339
-2.69%
|
$340,106
$254.81 P/Share
|
|
Nov 23
2021
|
Robert Andrew Douglas Special Advisor |
SELL
Bona fide gift
|
Indirect |
791
-0.34%
|
-
|
|
Nov 22
2021
|
Carol Burt Director |
SELL
Open market or private sale
|
Direct |
1,500
-10.28%
|
$390,000
$260.0 P/Share
|
|
Nov 19
2021
|
Michael J. Farrell Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
44,250
-9.84%
|
-
|
|
Nov 18
2021
|
Carol Burt Director |
BUY
Grant, award, or other acquisition
|
Direct |
956
+6.15%
|
-
|
|
Nov 18
2021
|
Ronald R Taylor Director |
BUY
Grant, award, or other acquisition
|
Direct |
956
+4.62%
|
-
|
|
Nov 18
2021
|
Jan De Witte Director |
BUY
Grant, award, or other acquisition
|
Direct |
956
+16.08%
|
-
|
|
Nov 18
2021
|
Harjit Gill Director |
BUY
Grant, award, or other acquisition
|
Direct |
956
+13.39%
|
-
|
|
Nov 18
2021
|
Resmed Inc Director |
BUY
Grant, award, or other acquisition
|
Direct |
956
+6.47%
|
-
|
|
Nov 18
2021
|
Peter C Farrell Director |
BUY
Grant, award, or other acquisition
|
Direct |
478
+0.25%
|
-
|
|
Nov 18
2021
|
Karen Drexler Director |
BUY
Grant, award, or other acquisition
|
Direct |
478
+6.02%
|
-
|
|
Nov 18
2021
|
David Pendarvis Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct |
986
+0.82%
|
-
|
|
Nov 18
2021
|
Robert Andrew Douglas Special Advisor |
BUY
Grant, award, or other acquisition
|
Direct |
2,612
+5.78%
|
-
|
|
Nov 18
2021
|
James Hollingshead President, Sleep Business |
BUY
Grant, award, or other acquisition
|
Direct |
1,709
+1.07%
|
-
|
|
Nov 18
2021
|
Kaushik Ghoshal Chief Commercial Officer, SaaS |
BUY
Grant, award, or other acquisition
|
Direct |
697
+5.87%
|
-
|
|
Nov 18
2021
|
Justin Leong Chief Product Officer |
BUY
Grant, award, or other acquisition
|
Direct |
638
+1.25%
|
-
|
|
Nov 18
2021
|
Brett Sandercock Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,161
+1.08%
|
-
|
|
Nov 18
2021
|
Michael J. Farrell Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,469
+0.98%
|
-
|
|
Nov 17
2021
|
David Pendarvis Chief Administrative Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,655
-7.56%
|
$2,452,370
$254.81 P/Share
|
|
Nov 17
2021
|
Robert Andrew Douglas Special Advisor |
SELL
Payment of exercise price or tax liability
|
Direct |
27,135
-40.45%
|
$6,892,290
$254.81 P/Share
|
|
Nov 17
2021
|
James Hollingshead President, Sleep Business |
SELL
Payment of exercise price or tax liability
|
Direct |
12,060
-13.48%
|
$3,063,240
$254.81 P/Share
|
|
Nov 17
2021
|
Kaushik Ghoshal Chief Commercial Officer, SaaS |
SELL
Payment of exercise price or tax liability
|
Direct |
5,112
-32.8%
|
$1,298,448
$254.81 P/Share
|
|
Nov 17
2021
|
Michael J. Farrell Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
42,210
-8.66%
|
$10,721,340
$254.81 P/Share
|
|
Nov 16
2021
|
David Pendarvis Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,307
+11.93%
|
$4,395,978
$254.81 P/Share
|
|
Nov 16
2021
|
Robert Andrew Douglas Special Advisor |
BUY
Grant, award, or other acquisition
|
Direct |
45,811
+40.58%
|
$11,635,994
$254.81 P/Share
|
|
Nov 16
2021
|
James Hollingshead President, Sleep Business |
BUY
Grant, award, or other acquisition
|
Direct |
20,360
+18.54%
|
$5,171,440
$254.81 P/Share
|
|
Nov 16
2021
|
Kaushik Ghoshal Chief Commercial Officer, SaaS |
BUY
Grant, award, or other acquisition
|
Direct |
9,162
+37.02%
|
$2,327,148
$254.81 P/Share
|
|
Nov 16
2021
|
Justin Leong Chief Product Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,162
+15.52%
|
$2,327,148
$254.81 P/Share
|
|
Nov 16
2021
|
Brett Sandercock Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,360
+16.22%
|
$5,171,440
$254.81 P/Share
|
|
Nov 16
2021
|
Michael J. Farrell Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
71,262
+12.76%
|
$18,100,548
$254.81 P/Share
|
|
Nov 15
2021
|
Carol Burt Director |
SELL
Open market or private sale
|
Direct |
1,187
-100.0%
|
$320,490
$270.8 P/Share
|
|
Nov 15
2021
|
Robert Andrew Douglas Special Advisor |
SELL
Open market or private sale
|
Direct |
8,000
-27.34%
|
$2,168,000
$271.75 P/Share
|
|
Nov 15
2021
|
Robert Andrew Douglas Special Advisor |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+21.47%
|
$464,000
$58.24 P/Share
|
|
Nov 11
2021
|
Michael J. Farrell Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,748
-2.06%
|
$2,265,732
$259.47 P/Share
|
|
Nov 11
2021
|
Jan De Witte Director |
SELL
Payment of exercise price or tax liability
|
Direct |
104
-2.51%
|
$26,936
$259.47 P/Share
|
|
Nov 11
2021
|
Peter C Farrell Director |
SELL
Payment of exercise price or tax liability
|
Direct |
342
-0.18%
|
$88,578
$259.47 P/Share
|
|
Nov 11
2021
|
Kaushik Ghoshal Chief Commercial Officer, SaaS |
SELL
Payment of exercise price or tax liability
|
Direct |
976
-13.19%
|
$252,784
$259.47 P/Share
|
|
Nov 11
2021
|
James Hollingshead President, Sleep Business |
SELL
Payment of exercise price or tax liability
|
Direct |
4,100
-5.6%
|
$1,061,900
$259.47 P/Share
|
|
Nov 11
2021
|
David Pendarvis Chief Administrative Officer |
SELL
Bona fide gift
|
Direct |
10,000
-8.3%
|
-
|
|
Nov 11
2021
|
David Pendarvis Chief Administrative Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
983
+0.81%
|
$99,283
$101.64 P/Share
|